| [1] |
1 Kraemer S, Jaeger WH, Lang N. Growth regulation effects of gonadotropin induced steroidogenic response in human ovarian cancer[J]. Anticancer Res, 2001, 21(3B): 2005~2010
2 Stein CA, Cheng YC. Antisense oligonucleotides as therapeutic agents—is the bullet really magical [J]. Science, 1993, 261(5124): 1004~1012
3 Shoham Z. Epidemiology, etiology, and fertility drugs in ovarian epithelial carcinoma: where are we today[J]. Fertil Steril, 1994, 62 (3): 433~448
4 Syed V, Ulinski G, Mok SC, et al. Expression of gonadotropin receptor and growth responses to key reproductive hormones in normal and malignant human ovarian surface epithelial cells[J]. Cancer Res, 2001, 61(18): 6768~6776
5 Parrott JA, Doraiswamy V, Kim G, et al. Expression and actions of both the follicle stimulating hormone receptor and the luteinizing hormone receptor in normal ovarian surface epithelium and ovarian cancer[J]. Mol Cell Endocrinol, 2001, 172(1~2): 213~222
6 Albanese C, Christin- Maitre S, Sluss PM, et al. Development of a bioassay for FSH using a recombinant human FSH receptor and a cAMP responsive luciferase reporter gene[J]. Mol Cell Endocrinol, 1994, 101(1~2): 211~219
7 Zachos NC, Billiar RB, Albrecht ED, et al. Developmental regulation of follicle- stimulating hormone receptor messenger RNA expression in the baboon fetal ovary[J]. Biol Reprod, 2003, 68(5): 1911~1917
8 Nakano R, Kitayama S, Yamoto M,et al. Localization of gonadotropin binding sites in human ovarian neoplasms [J]. Am J Obstet Gynecol, 1989, 161(4): 905~910
9 Zhu C, Wang Y, Nixon MD, et al. Antisense oligodeoxynucleotide inhibits expression of recombinant porcine follicle- stimulatinghormonereceptor[J]. MolReprod Dev, 2003, 65(2): 188~193
10 Kene PS, Nalavadi VC, Dighe RR, et al. Identification of the structural and functional determinants of the extracellular domain of the human follicle stimulating hormone receptor [J]. J Endocrinol, 2004, 182(3): 501~508
|
下载:
